Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms (Q54531924)
scientific article published on September 1, 1981
Language:
Current Data About Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms
(P31) (Q13442814)
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P304) 435-442
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P407) (Q1860)

(P433) 3
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P478) 71
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P577) Tuesday, September 1, 1981
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P921) (Q643839)
(P887)

(Q417968)
(P887)

(Q311379)
(P887)

(P953) https://api.elsevier.com/content/article/PII:000293438190173X?httpAccept=text/xml
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

https://api.elsevier.com/content/article/PII:000293438190173X?httpAccept=text/plain
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(P1433) (Q2842959)
(P248)
(P698) 6269426
(P813) Thursday, May 31, 2018
(P854) http://europepmc.org/abstract/MED/6269426

(P1476) "Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms" (language: en)
(P7452)
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

"Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms" (language: en)
(P248)
(P698) 6269426
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269426
(P813) Tuesday, September 12, 2023

(P2093) E. L. Francke
(P1545) 1
(P248)
(P698) 6269426
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269426
(P813) Tuesday, September 12, 2023

H. C. Neu
(P1545) 2
(P248)
(P698) 6269426
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269426
(P813) Tuesday, September 12, 2023

(P2860) (Q40620012)
(P1545) 1
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(Q43470846)
(P1545) 2
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(Q38112663)
(P1545) 3
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(Q40621252)
(P1545) 4
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(Q40281304)
(P1545) 7
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

(Q54559072)
(P1545) 9
(P248)
(P356) 10.1016/0002-9343(81)90173-X
(P854) https://api.crossref.org/works/10.1016/0002-9343(81)90173-X
(P813) Tuesday, September 12, 2023

other details
description scientific article published on September 1, 1981

External Links
(P356) 10.1016/0002-9343(81)90173-X
(P698) 6269426